Watchlist Price Alert

Moleculin Biotech Inc. (MBRX)

NASDAQ: MBRX · Real-Time Price · USD

0.96

-0.02 (-2.03%)

At close: May 21, 2025, 3:08 PM

Moleculin Biotech Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	126K	127K	222K	260K	285K	185K	68K	18K	6.16K
Gross Profit	n/a	-127K	-222K	-260K	-285K	-185K	-68K	-18K	-6.16K
Operating Income	-26.64M	-29.63M	-30.64M	-22.97M	-19.74M	-17.52M	-15.03M	-8.65M	-3.88M
Interest Income	n/a	1.37M	240K	306K	13K	13K	n/a	n/a	n/a
Pretax Income	-21.76M	-29.77M	-29.02M	-15.89M	-17.36M	-13.43M	-11.88M	-9.8M	-3.93M
Net Income	-21.76M	-29.77M	-27.41M	-8.86M	-15M	-13.21M	-11.88M	-9.8M	-3.93M
Selling & General & Admin	8.79M	10.02M	11.67M	8.39M	6.79M	6.31M	5.3M	4.09M	2.38M
Research & Development	17.73M	19.49M	18.97M	14.42M	12.76M	11.01M	9.73M	4.54M	1.5M
Other Expenses	126K	127K	40K	164K	200K	199K	-40K	18K	6.16K
Operating Expenses	26.64M	29.63M	30.64M	22.97M	19.74M	17.52M	15.03M	8.65M	3.88M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	43.21K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	29.63M	30.64M	22.97M	19.74M	17.52M	15.03M	8.65M	3.88M
Income Tax Expense	n/a	n/a	-1.61M	-7.03M	-2.36M	-229K	3.15M	1.15M	n/a
Shares Outstanding (Basic)	3.44M	1.98M	1.91M	1.79M	656.38K	452.46K	287.82K	206.32K	109.19K
Shares Outstanding (Diluted)	3.44M	1.98M	1.91M	1.79M	656.38K	452.46K	287.82K	206.32K	109.19K
EPS (Basic)	-6.32	-15.07	-14.37	-4.94	-22.85	-29.18	-41.26	-47.52	-35.96
EPS (Diluted)	-6.32	-15.07	-14.37	-4.94	-22.85	-29.18	-41.26	-47.52	-35.96
EBITDA	-21.64M	-29.5M	-30.51M	-22.8M	-19.54M	-13.25M	-14.96M	-8.63M	-3.88M
EBIT	-21.76M	-29.63M	-30.64M	-22.97M	-19.74M	-17.52M	-15.06M	-8.49M	-3.88M
Depreciation & Amortization	126K	127K	222K	260K	285K	185K	68K	18K	6.16K